{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:07:02Z","timestamp":1792804022201,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10482-025-02208-3","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:33:00Z","timestamp":1763386380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in combating antimicrobial resistance in MRSA: a comprehensive review on nanotechnology and phage therapy"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7576-1627","authenticated-orcid":false,"given":"Deepak Chandra","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri Bapu","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita Walia","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprabha","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2208_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-023-00574-2","author":"AI AbdAlhafiz","year":"2023","unstructured":"AbdAlhafiz AI, Elleboudy NS, Aboshanab KM, Aboulwafa MM, Hassouna NA (2023) Phenotypic and genotypic characterization of linezolid resistance and the effect of antibiotic combinations on methicillin-resistant Staphylococcus aureus clinical isolates. Ann Clin Microbiol Antimicrob. https:\/\/doi.org\/10.1186\/s12941-023-00574-2","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2208_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12941-021-00459-2\/TABLES\/3","volume":"20","author":"WM Abdelraheem","year":"2021","unstructured":"Abdelraheem WM, Khairy RMM, Zaki AI, Zaki SH (2021) Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance, and biofilm formation in Staphylococcus aureus isolates. Ann Clin Microbiol Antimicrob 20:1\u201311. https:\/\/doi.org\/10.1186\/S12941-021-00459-2\/TABLES\/3","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2208_CR3","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.2147\/IDR.S428103","volume":"16","author":"AA Abebe","year":"2023","unstructured":"Abebe AA, Birhanu AG (2023) Methicillin resistant Staphylococcus aureus: molecular mechanisms underlying drug resistance development and novel strategies to combat. Infect Drug Resist 16:7641. https:\/\/doi.org\/10.2147\/IDR.S428103","journal-title":"Infect Drug Resist"},{"key":"2208_CR4","doi-asserted-by":"publisher","first-page":"e09761","DOI":"10.1016\/J.HELIYON.2022.E09761","volume":"8","author":"ON Aguda","year":"2022","unstructured":"Aguda ON, Lateef A (2022) Recent advances in functionalization of nanotextiles: a strategy to combat harmful microorganisms and emerging pathogens in the 21st century. Heliyon 8:e09761. https:\/\/doi.org\/10.1016\/J.HELIYON.2022.E09761","journal-title":"Heliyon"},{"key":"2208_CR5","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.3390\/IJMS25137182","volume":"25","author":"S Alfei","year":"2024","unstructured":"Alfei S, Schito GC, Schito AM, Zuccari G (2024) Reactive oxygen species (ROS)-mediated antibacterial oxidative therapies: available methods to generate ROS and a novel option proposal. Int J Mol Sci 25:7182. https:\/\/doi.org\/10.3390\/IJMS25137182","journal-title":"Int J Mol Sci"},{"key":"2208_CR6","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1016\/J.ONANO.2022.100077","volume":"8","author":"AW Alshameri","year":"2022","unstructured":"Alshameri AW, Owais M (2022) Antibacterial and cytotoxic potency of the plant-mediated synthesis of metallic nanoparticles Ag NPs and ZnO NPs: a review. OpenNano 8:100077. https:\/\/doi.org\/10.1016\/J.ONANO.2022.100077","journal-title":"OpenNano"},{"key":"2208_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109030","author":"S Andrade","year":"2023","unstructured":"Andrade S, Ramalho MJ, Santos SB, Melo LDR, Santos RS, Guimar\u00e3es N et al (2023) Fighting methicillin-resistant Staphylococcus aureus with targeted nanoparticles. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24109030","journal-title":"Int J Mol Sci"},{"key":"2208_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40273-014-0242-y","volume":"33","author":"F Antonanzas","year":"2015","unstructured":"Antonanzas F, Lozano C, Torres C (2015) Economic features of antibiotic resistance: the case of Methicillin-resistant Staphylococcus aureus. Pharmacoeconomics 33:285\u2013325. https:\/\/doi.org\/10.1007\/s40273-014-0242-y","journal-title":"Pharmacoeconomics"},{"key":"2208_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020310","author":"K Arunachalam","year":"2023","unstructured":"Arunachalam K, Pandurangan P, Shi C, Lagoa R (2023) Regulation of Staphylococcus aureus virulence and application of nanotherapeutics to eradicate S. aureus infection. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020310","journal-title":"Pharmaceutics"},{"key":"2208_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3121\/cmr.2021.1605","volume":"19","author":"VH Aswani","year":"2021","unstructured":"Aswani VH, Shukla SK (2021) An early history of phage therapy in the United States: is it time to reconsider? Clin Med Res 19:82\u20139. https:\/\/doi.org\/10.3121\/cmr.2021.1605","journal-title":"Clin Med Res"},{"key":"2208_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/PH15020194\/S1","volume":"15","author":"NGM Attallah","year":"2022","unstructured":"Attallah NGM, Elekhnawy E, Negm WA, Hussein IA, Mokhtar FA, Al-Fakhrany OM (2022) In vivo and in vitro antimicrobial activity of biogenic silver nanoparticles against Staphylococcus aureus clinical isolates. Pharmaceuticals 15:194. https:\/\/doi.org\/10.3390\/PH15020194\/S1","journal-title":"Pharmaceuticals"},{"key":"2208_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/ANTIBIOTICS11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F et al (2022) Mechanisms of action of carbapenem resistance. Antibiotics 11:421. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11030421","journal-title":"Antibiotics"},{"key":"2208_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s44149-023-00065-z","author":"FB Balcha","year":"2023","unstructured":"Balcha FB, Neja SA (2023) CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics. Anim Dis. https:\/\/doi.org\/10.1186\/s44149-023-00065-z","journal-title":"Anim Dis"},{"key":"2208_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3390\/MICRO3040058","volume":"2023","author":"A Bezelya","year":"2023","unstructured":"Bezelya A, K\u00fc\u00e7\u00fckt\u00fcrkmen B, Bozk\u0131r A (2023) Microfluidic devices for precision nanoparticle production. Micro 2023:822\u2013866. https:\/\/doi.org\/10.3390\/MICRO3040058","journal-title":"Micro"},{"key":"2208_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/J.JCONREL.2022.05.021","volume":"347","author":"T Briot","year":"2022","unstructured":"Briot T, Kolenda C, Ferry T, Medina M, Laurent F, Leboucher G et al (2022) Paving the way for phage therapy using novel drug delivery approaches. J Control Release 347:414\u201324. https:\/\/doi.org\/10.1016\/J.JCONREL.2022.05.021","journal-title":"J Control Release"},{"key":"2208_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/MICROORGANISMS13040952","volume":"13","author":"E Casals","year":"2025","unstructured":"Casals E, Gusta MF, Bastus N, Rello J, Puntes V (2025) Silver nanoparticles and antibiotics: a promising synergistic approach to multidrug-resistant infections. Microorganisms 13:952. https:\/\/doi.org\/10.3390\/MICROORGANISMS13040952","journal-title":"Microorganisms"},{"key":"2208_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.825828","author":"C Chang","year":"2022","unstructured":"Chang C, Yu X, Guo W, Guo C, Guo X, Li Q et al (2022) Bacteriophage-mediated control of biofilm: a promising new dawn for the future. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.825828","journal-title":"Front Microbiol"},{"key":"2208_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"GYC Cheung","year":"2021","unstructured":"Cheung GYC, Bae JS, Otto M (2021) Pathogenicity and virulence of Staphylococcus aureus. Virulence 12:547\u201369. https:\/\/doi.org\/10.1080\/21505594.2021.1878688","journal-title":"Virulence"},{"key":"2208_CR20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1021\/ACSINFECDIS.4C00128\/ASSET\/IMAGES\/LARGE\/ID4C00128_0009.JPEG","volume":"10","author":"JA Collins","year":"2024","unstructured":"Collins JA, Osheroff N (2024) Gyrase and topoisomerase IV: recycling old targets for new antibacterials to combat fluoroquinolone resistance. ACS Infect Dis 10:1097\u2013115. https:\/\/doi.org\/10.1021\/ACSINFECDIS.4C00128\/ASSET\/IMAGES\/LARGE\/ID4C00128_0009.JPEG","journal-title":"ACS Infect Dis"},{"key":"2208_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/ANTIBIOTICS13090870","volume":"13","author":"L Cui","year":"2024","unstructured":"Cui L, Watanabe S, Miyanaga K, Kiga K, Sasahara T, Aiba Y et al (2024) A comprehensive review on phage therapy and phage-based drug development. Antibiotics 13:870. https:\/\/doi.org\/10.3390\/ANTIBIOTICS13090870","journal-title":"Antibiotics"},{"key":"2208_CR22","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1021\/acssynbio.1c00629","volume":"11","author":"TG Cunliffe","year":"2022","unstructured":"Cunliffe TG, Parker AL, Jaramillo A (2022) Pseudotyping bacteriophage P2 tail fibers to extend the host range for biomedical applications. ACS Synth Biol 11:3207\u201315. https:\/\/doi.org\/10.1021\/acssynbio.1c00629","journal-title":"ACS Synth Biol"},{"key":"2208_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/S12951-024-02501-9","volume":"22","author":"Y Dai","year":"2024","unstructured":"Dai Y, Guo Y, Tang W, Chen D, Xue L, Chen Y et al (2024) Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases. J Nanobiotechnol 22:252. https:\/\/doi.org\/10.1186\/S12951-024-02501-9","journal-title":"J Nanobiotechnol"},{"key":"2208_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/S42770-020-00406-X","volume":"52","author":"D de Lacerda Coriolano","year":"2020","unstructured":"de Lacerda Coriolano D, de Souza JB, Bueno EV, Medeiros SM, Cavalcanti ID, Cavalcanti IM (2020) Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains. Braz J Microbiol 52:267. https:\/\/doi.org\/10.1007\/S42770-020-00406-X","journal-title":"Braz J Microbiol"},{"key":"2208_CR25","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/J.ADDR.2005.09.019","volume":"57","author":"R Duncan","year":"2005","unstructured":"Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57:2215\u201337. https:\/\/doi.org\/10.1016\/J.ADDR.2005.09.019","journal-title":"Adv Drug Deliv Rev"},{"key":"2208_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/ANTIBIOTICS12060972","volume":"12","author":"M Ejaz","year":"2023","unstructured":"Ejaz M, Syed MA, Jackson CR, Sharif M, Faryal R (2023) Epidemiology of Staphylococcus aureus non-susceptible to vancomycin in South Asia. Antibiotics 12:972. https:\/\/doi.org\/10.3390\/ANTIBIOTICS12060972","journal-title":"Antibiotics"},{"key":"2208_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13568-025-01837-1","volume":"15","author":"AA Elshamy","year":"2025","unstructured":"Elshamy AA, Kamal SK, Mahmoud MT, Elhasany AM, Shady AA, Mohamed SA et al (2025) Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii. AMB Express 15:1\u201316. https:\/\/doi.org\/10.1186\/S13568-025-01837-1","journal-title":"AMB Express"},{"issue":"2","key":"2208_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/BIOMEDICINES13020378","volume":"13","author":"E Erdene","year":"2025","unstructured":"Erdene E, Munkhjargal O, Batnasan G, Dorjbal E, Oidov B, Byambaa A (2025) Evaluation of liposome-encapsulated vancomycin against methicillin-resistant Staphylococcus aureus. Biomedicines 13(2):378. https:\/\/doi.org\/10.3390\/BIOMEDICINES13020378","journal-title":"Biomedicines"},{"key":"2208_CR30","unstructured":"European Centre for Disease Prevention and Control and World Health Organization (2023) Antimicrobial resistance surveillance in Europe 2023: 2021 data"},{"key":"2208_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01662-2","author":"NE Fakhoury","year":"2024","unstructured":"Fakhoury NE, Mansour S, Abdel-Halim M, Hamed MM, Empting M, Boese A et al (2024) Nanoparticles in liposomes: a platform for increased antibiotic selectivity in multidrug-resistant bacteria in respiratory tract infections. Drug Deliv Transl Res. https:\/\/doi.org\/10.1007\/s13346-024-01662-2","journal-title":"Drug Deliv Transl Res"},{"key":"2208_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jfb14020115","author":"B Farasati Far","year":"2023","unstructured":"Farasati Far B, Naimi-Jamal MR, Sedaghat M, Hoseini A, Mohammadi N, Bodaghi M (2023) Combinational system of lipid-based nanocarriers and biodegradable polymers for wound healing: an updated review. J Funct Biomater. https:\/\/doi.org\/10.3390\/jfb14020115","journal-title":"J Funct Biomater"},{"key":"2208_CR33","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/J.IMJ.2025.100168","volume":"4","author":"O Faruk","year":"2025","unstructured":"Faruk O, Jewel ZA, Bairagi S, Rasheduzzaman M, Bagchi H, Tuha ASM et al (2025) Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: the current status and future prospects. Infect Med 4:100168. https:\/\/doi.org\/10.1016\/J.IMJ.2025.100168","journal-title":"Infect Med"},{"key":"2208_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072375","author":"Z Ferdous","year":"2020","unstructured":"Ferdous Z, Nemmar A (2020) Health impact of silver nanoparticles: a review of the biodistribution and toxicity following various routes of exposure. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21072375","journal-title":"Int J Mol Sci"},{"key":"2208_CR35","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.3390\/APP14188137","volume":"14","author":"MP Ferraz","year":"2024","unstructured":"Ferraz MP (2024) Advanced nanotechnological approaches for biofilm prevention and control. Appl Sci 14:8137. https:\/\/doi.org\/10.3390\/APP14188137","journal-title":"Appl Sci"},{"key":"2208_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26072047","author":"M Ferreira","year":"2021","unstructured":"Ferreira M, Ogren M, Dias JNR, Silva M, Gil S, Tavares L et al (2021) Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance. Molecules. https:\/\/doi.org\/10.3390\/molecules26072047","journal-title":"Molecules"},{"key":"2208_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1556\/1886.2023.00064","volume":"14","author":"JAG Fortaleza","year":"2024","unstructured":"Fortaleza JAG, Ong CJN, De Jesus R (2024) Efficacy and clinical potential of phage therapy in treating methicillin-resistant Staphylococcus aureus (MRSA) infections: a review. Eur J Microbiol Immunol (Bp) 14:13. https:\/\/doi.org\/10.1556\/1886.2023.00064","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"2208_CR38","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3390\/NANO11092337","volume":"11","author":"RP Friedrich","year":"2021","unstructured":"Friedrich RP, Cicha I, Alexiou C (2021) Iron oxide nanoparticles in regenerative medicine and tissue engineering. Nanomaterials 11:2337. https:\/\/doi.org\/10.3390\/NANO11092337","journal-title":"Nanomaterials"},{"key":"2208_CR39","doi-asserted-by":"publisher","first-page":"15628","DOI":"10.3390\/IJMS242115628","volume":"24","author":"J Fujiki","year":"2023","unstructured":"Fujiki J, Nakamura K, Nakamura T, Iwano H (2023) Fitness trade-offs between phage and antibiotic sensitivity in phage-resistant variants: molecular action and insights into clinical applications for phage therapy. Int J Mol Sci 24:15628. https:\/\/doi.org\/10.3390\/IJMS242115628","journal-title":"Int J Mol Sci"},{"key":"2208_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/PHARMACEUTICS16040459\/S1","volume":"16","author":"F Gkartziou","year":"2024","unstructured":"Gkartziou F, Plota M, Kypraiou C, Gauttam I, Kolonitsiou F, Klepetsanis P et al (2024) Daptomycin liposomes exhibit enhanced activity against Staphylococci biofilms compared to free drug. Pharmaceutics 16:459. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16040459\/S1","journal-title":"Pharmaceutics"},{"key":"2208_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/S10096-025-05157-X\/TABLES\/3","author":"NB Goda","year":"2025","unstructured":"Goda NB, El-Ganiny AM, El-khamissy TR, Najar FZ, Kadry AA (2025) Identification of genetic mutations conferring tedizolid resistance in MRSA mutants. Eur J Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1007\/S10096-025-05157-X\/TABLES\/3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2208_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/J.EBIOM.2022.104045","author":"FL Gordillo Altamirano","year":"2022","unstructured":"Gordillo Altamirano FL, Kostoulias X, Subedi D, Korneev D, Peleg AY, Barr JJ (2022) Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. EBioMedicine. https:\/\/doi.org\/10.1016\/J.EBIOM.2022.104045","journal-title":"EBioMedicine"},{"key":"2208_CR43","doi-asserted-by":"publisher","first-page":"126746","DOI":"10.1016\/J.MICRES.2021.126746","volume":"248","author":"\u0141 Grabowski","year":"2021","unstructured":"Grabowski \u0141, \u0141epek K, Stasi\u0142oj\u0107 M, Kosznik-Kwa\u015bnicka K, Zdrojewska K, Maci\u0105g-Dorszy\u0144ska M et al (2021) Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents. Microbiol Res 248:126746. https:\/\/doi.org\/10.1016\/J.MICRES.2021.126746","journal-title":"Microbiol Res"},{"key":"2208_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/1061186X.2011.654121","volume":"20","author":"A Grenha","year":"2012","unstructured":"Grenha A (2012) Chitosan nanoparticles: a survey of preparation methods. J Drug Target 20:291\u2013300. https:\/\/doi.org\/10.3109\/1061186X.2011.654121","journal-title":"J Drug Target"},{"key":"2208_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S44337-025-00300-1","volume":"2","author":"NM Hajhamed","year":"2025","unstructured":"Hajhamed NM, Mohamed NS, Abdalla AE et al (2025) Current status and recent trends in innovative tactics and the one health approach to address the challenge of methicillin-resistant Staphylococcus aureus infections: a comprehensive review. Discover Med 2:1\u201322. https:\/\/doi.org\/10.1007\/S44337-025-00300-1","journal-title":"Discover Med"},{"key":"2208_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/J.JHIN.2020.04.007","author":"DC Ham","year":"2020","unstructured":"Ham DC, See I, Novosad S, Crist M, Mahon G, Fike L et al (2020) Investigation of hospital-onset meticillin-resistant Staphylococcus aureus bloodstream infections at eight high-burden acute care facilities in the USA, 2016. J Hosp Infect. https:\/\/doi.org\/10.1016\/J.JHIN.2020.04.007","journal-title":"J Hosp Infect"},{"key":"2208_CR47","doi-asserted-by":"publisher","first-page":"102767","DOI":"10.1016\/J.COPBIO.2022.102767","volume":"77","author":"MH Hansen","year":"2022","unstructured":"Hansen MH, Stegmann E, Cryle MJ (2022) Beyond vancomycin: recent advances in the modification, reengineering, production and discovery of improved glycopeptide antibiotics to tackle multidrug-resistant bacteria. Curr Opin Biotechnol 77:102767. https:\/\/doi.org\/10.1016\/J.COPBIO.2022.102767","journal-title":"Curr Opin Biotechnol"},{"key":"2208_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-023-01210-6","author":"AH Hasanpour","year":"2023","unstructured":"Hasanpour AH, Sepidarkish M, Mollalo A, Ardekani A, Almukhtar M, Mechaal A et al (2023) The global prevalence of methicillin-resistant Staphylococcus aureus colonization in residents of elderly care centers: a systematic review and meta-analysis. Antimicrob Resist Infect Control. https:\/\/doi.org\/10.1186\/s13756-023-01210-6","journal-title":"Antimicrob Resist Infect Control"},{"key":"2208_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/BTT.S381237","volume":"16","author":"Z Hibstu","year":"2022","unstructured":"Hibstu Z, Belew H, Akelew Y, Mengist HM (2022) Phage therapy: a different approach to fight bacterial infections. Biologics 16:173. https:\/\/doi.org\/10.2147\/BTT.S381237","journal-title":"Biologics"},{"key":"2208_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-024-01383-8","author":"A Hirabayashi","year":"2024","unstructured":"Hirabayashi A, Yahara K, Oka K, Kajihara T, Ohkura T, Hosaka Y et al (2024) Comparison of disease and economic burden between MRSA infection and MRSA colonization in a university hospital: a retrospective data integration study. Antimicrob Resist Infect Control. https:\/\/doi.org\/10.1186\/s13756-024-01383-8","journal-title":"Antimicrob Resist Infect Control"},{"key":"2208_CR51","doi-asserted-by":"publisher","first-page":"102488","DOI":"10.1016\/J.JIPH.2024.102488","volume":"17","author":"M Hirose","year":"2024","unstructured":"Hirose M, Aung MS, Fujita Y, Sakakibara S, Minowa-Suzuki E, Otomo M et al (2024) Prevalence, genetic characteristics, and antimicrobial resistance of staphylococcal isolates from oral cavity and skin surface of healthy individuals in northern Japan. J Infect Public Health 17:102488. https:\/\/doi.org\/10.1016\/J.JIPH.2024.102488","journal-title":"J Infect Public Health"},{"key":"2208_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020615","author":"D Horvath","year":"2023","unstructured":"Horvath D, Basler M (2023) PLGA particles in immunotherapy. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020615","journal-title":"Pharmaceutics"},{"key":"2208_CR53","doi-asserted-by":"publisher","first-page":"11773","DOI":"10.3390\/IJMS252111773","volume":"25","author":"J Hou","year":"2024","unstructured":"Hou J, Wu Q, Xiong R, Malakar PK, Zhu Y, Zhao Y et al (2024) A standardized mouse model for wound infection with Pseudomonas aeruginosa. Int J Mol Sci 25:11773. https:\/\/doi.org\/10.3390\/IJMS252111773","journal-title":"Int J Mol Sci"},{"key":"2208_CR54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/ANTIBIOTICS11040520","volume":"11","author":"L Huang","year":"2022","unstructured":"Huang L, Wu C, Gao H, Xu C, Dai M, Huang L et al (2022) Bacterial multidrug efflux pumps at the frontline of antimicrobial resistance: an overview. Antibiotics 11:520. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11040520","journal-title":"Antibiotics"},{"key":"2208_CR55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.76.3.209","author":"NK Jerne","year":"1956","unstructured":"Jerne NK (1956) The presence in normal serum of specific antibody against bacteriophage T4 and its increase during the earliest stages of immunization. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.76.3.209","journal-title":"J Immunol"},{"key":"2208_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S10544-023-00686-8\/FIGURES\/5","volume":"26","author":"H Jiang","year":"2024","unstructured":"Jiang H, Li L, Li Z, Chu X (2024) Metal-based nanoparticles in antibacterial application in biomedical field: current development and potential mechanisms. Biomed Microdev 26:1\u201315. https:\/\/doi.org\/10.1007\/S10544-023-00686-8\/FIGURES\/5","journal-title":"Biomed Microdev"},{"key":"2208_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.699054","author":"S Kaur","year":"2021","unstructured":"Kaur S, Kumari A, Kumari Negi A, Galav V, Thakur S, Agrawal M et al (2021) Nanotechnology based approaches in phage therapy: overcoming the pharmacological barriers. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.699054","journal-title":"Front Pharmacol"},{"key":"2208_CR58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/PATHOGENS13010076","volume":"13","author":"A Kaushik","year":"2024","unstructured":"Kaushik A, Kest H, Sood M, Steussy BW, Thieman C, Gupta S (2024) Biofilm producing methicillin-resistant Staphylococcus aureus (MRSA) infections in humans: clinical implications and management. Pathogens 13:76. https:\/\/doi.org\/10.3390\/PATHOGENS13010076","journal-title":"Pathogens"},{"key":"2208_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02085-18","author":"M Kim","year":"2018","unstructured":"Kim M, Jo Y, Hwang YJ, Hong HW, Hong SS, Park K et al (2018) Phageantibiotic synergy via delayed lysis. Appl Environ Microbiol. https:\/\/doi.org\/10.1128\/AEM.02085-18","journal-title":"Appl Environ Microbiol"},{"key":"2208_CR60","doi-asserted-by":"publisher","first-page":"e187996","DOI":"10.1172\/JCI187996","volume":"135","author":"MK Kim","year":"2025","unstructured":"Kim MK, Suh GA, Cullen GD, Rodriguez SP, Dharmaraj T, Chang THW et al (2025) Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches. J Clin Invest 135:e187996. https:\/\/doi.org\/10.1172\/JCI187996","journal-title":"J Clin Invest"},{"key":"2208_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano10101911","volume":"10","author":"Y Kohl","year":"2020","unstructured":"Kohl Y, Rund\u00e9n-Pran E, Mariussen E, Hesler M, El Yamani N, Longhin EM et al (2020) Genotoxicity of nanomaterials: advanced in vitro models and high-throughput methods for human hazard assessment\u2014a review. Nanomaterials 10:1\u201325. https:\/\/doi.org\/10.3390\/nano10101911","journal-title":"Nanomaterials"},{"key":"2208_CR62","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4155\/FMC-2023-0116","volume":"16","author":"M Kr\u00e1tk\u00fd","year":"2024","unstructured":"Kr\u00e1tk\u00fd M (2024) Novel sulfonamide derivatives as a tool to combat methicillin-resistant Staphylococcus aureus. Future Med Chem 16:545\u201362. https:\/\/doi.org\/10.4155\/FMC-2023-0116","journal-title":"Future Med Chem"},{"key":"2208_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27020473","author":"CY Kuen","year":"2022","unstructured":"Kuen CY, Masarudin MJ (2022) Chitosan nanoparticle-based system: a new insight into the promising controlled release system for lung cancer treatment. Molecules. https:\/\/doi.org\/10.3390\/molecules27020473","journal-title":"Molecules"},{"key":"2208_CR64","doi-asserted-by":"publisher","first-page":"1292509","DOI":"10.3389\/FMOLB.2023.1292509\/BIBTEX","volume":"10","author":"S Kumar","year":"2023","unstructured":"Kumar S, Khan HM, Husain FM, Ahmad R, Qais FA, Khan MA et al (2023) Antibacterial and antibiofilm activity of Abroma augusta stabilized silver (Ag) nanoparticles against drug-resistant clinical pathogens. Front Mol Biosci 10:1292509. https:\/\/doi.org\/10.3389\/FMOLB.2023.1292509\/BIBTEX","journal-title":"Front Mol Biosci"},{"key":"2208_CR65","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/ANTIBIOTICS12091362","volume":"12","author":"H Lade","year":"2023","unstructured":"Lade H, Kim JS (2023) Molecular determinants of \u03b2-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA): an updated review. Antibiotics 12:1362. https:\/\/doi.org\/10.3390\/ANTIBIOTICS12091362","journal-title":"Antibiotics"},{"key":"2208_CR66","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3390\/ANTIBIOTICS11101378","volume":"11","author":"H Lade","year":"2022","unstructured":"Lade H, Joo HS, Kim JS (2022) Molecular basis of non-\u03b2-lactam antibiotics resistance in Staphylococcus aureus. Antibiotics 11:1378. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11101378","journal-title":"Antibiotics"},{"key":"2208_CR67","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/IJBS.60551","volume":"17","author":"X Li","year":"2021","unstructured":"Li X, He Y, Wang Z, Wei J, Hu T, Si J et al (2021) A combination therapy of phages and antibiotics: two is better than one. Int J Biol Sci 17:3573\u201382. https:\/\/doi.org\/10.7150\/IJBS.60551","journal-title":"Int J Biol Sci"},{"key":"2208_CR68","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.60551","author":"X Li","year":"2021","unstructured":"Li X, He Y, Wang Z, Wei J, Hu T, Si J et al (2021) A combination therapy of phages and antibiotics: two is better than one. Int J Biol Sci. https:\/\/doi.org\/10.7150\/ijbs.60551","journal-title":"Int J Biol Sci"},{"key":"2208_CR69","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.3390\/IJMS26115337\/S1","volume":"26","author":"LC Lin","year":"2025","unstructured":"Lin LC, Tsai YC, Lin NT (2025) Phage-antibiotic synergy enhances biofilm eradication and survival in a zebrafish model of pseudomonas aeruginosa infection. Int J Mol Sci 26:5337. https:\/\/doi.org\/10.3390\/IJMS26115337\/S1","journal-title":"Int J Mol Sci"},{"key":"2208_CR70","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/J.APSB.2022.05.007","volume":"12","author":"H Ling","year":"2022","unstructured":"Ling H, Lou X, Luo Q, He Z, Sun M, Sun J (2022) Recent advances in bacteriophage-based therapeutics: insight into the post-antibiotic era. Acta Pharm Sin B 12:4348\u201364. https:\/\/doi.org\/10.1016\/J.APSB.2022.05.007","journal-title":"Acta Pharm Sin B"},{"key":"2208_CR71","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1038\/S41467-022-29689-4","volume":"13","author":"JS Little","year":"2022","unstructured":"Little JS, Dedrick RM, Freeman KG, Cristinziano M, Smith BE, Benson CA et al (2022) Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection. Nat Commun 13:2313. https:\/\/doi.org\/10.1038\/S41467-022-29689-4","journal-title":"Nat Commun"},{"key":"2208_CR72","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.7150\/thno.14858","volume":"6","author":"D Liu","year":"2016","unstructured":"Liu D, Yang F, Xiong F, Gu N (2016) The smart drug delivery system and its clinical potential. Theranostics 6:1306\u201323. https:\/\/doi.org\/10.7150\/thno.14858","journal-title":"Theranostics"},{"key":"2208_CR15","unstructured":"Locus Biosciences initiates world\u2019s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy - Locus Bioscience n.d. https:\/\/www.locus-bio.com\/locus-biosciences-initiates-worlds-first-controlled-clinical-trial\/ (accessed 7 Mar 2025)."},{"key":"2208_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/S12929-022-00806-1","volume":"29","author":"M \u0141usiak-Szelachowska","year":"2022","unstructured":"\u0141usiak-Szelachowska M, Mi\u0119dzybrodzki R, Drulis-Kawa Z, Cater K, Kne\u017eevi\u0107 P, Winogradow C et al (2022) Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far. J Biomed Sci 29:23. https:\/\/doi.org\/10.1186\/S12929-022-00806-1","journal-title":"J Biomed Sci"},{"key":"2208_CR74","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3390\/V15081736","volume":"15","author":"S Lv","year":"2023","unstructured":"Lv S, Wang Y, Jiang K, Guo X, Zhang J, Zhou F et al (2023) Genetic engineering and biosynthesis technology: keys to unlocking the chains of phage therapy. Viruses 15:1736. https:\/\/doi.org\/10.3390\/V15081736","journal-title":"Viruses"},{"key":"2208_CR75","doi-asserted-by":"publisher","first-page":"1456939","DOI":"10.3389\/FNANO.2024.1456939\/FULL","volume":"6","author":"PD Ly","year":"2024","unstructured":"Ly PD, Ly KN, Phan HL, Nguyen HHT, Duong VA, Nguyen HV (2024) Recent advances in surface decoration of nanoparticles in drug delivery. Front Nanotechnol 6:1456939. https:\/\/doi.org\/10.3389\/FNANO.2024.1456939\/FULL","journal-title":"Front Nanotechnol"},{"key":"2208_CR76","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as a biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377\u201397. https:\/\/doi.org\/10.3390\/polym3031377","journal-title":"Polymers (Basel)"},{"issue":"2","key":"2208_CR78","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/MICROORGANISMS10020437","volume":"10","author":"N Mammari","year":"2022","unstructured":"Mammari N, Lamouroux E, Boudier A, Duval RE (2022) Current knowledge on the oxidative-stress-mediated antimicrobial properties of metal-based nanoparticles. Microorganisms 10(2):437. https:\/\/doi.org\/10.3390\/MICROORGANISMS10020437","journal-title":"Microorganisms"},{"key":"2208_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12866-022-02738-0\/FIGURES\/8","volume":"23","author":"AG Mankovich","year":"2023","unstructured":"Mankovich AG, Maciel K, Kavanaugh M, Kistler E, Muckle E, Weingart CL (2023) Phage-antibiotic synergy reduces Burkholderia cenocepacia population. BMC Microbiol 23:1\u201312. https:\/\/doi.org\/10.1186\/S12866-022-02738-0\/FIGURES\/8","journal-title":"BMC Microbiol"},{"key":"2208_CR80","doi-asserted-by":"publisher","first-page":"1428637","DOI":"10.3389\/FCIMB.2024.1428637\/XML","volume":"14","author":"A Mayorga-Ramos","year":"2024","unstructured":"Mayorga-Ramos A, Carrera-Pacheco SE, Barba-Ostria C, Guam\u00e1n LP (2024) Bacteriophage-mediated approaches for biofilm control. Front Cell Infect Microbiol 14:1428637. https:\/\/doi.org\/10.3389\/FCIMB.2024.1428637\/XML","journal-title":"Front Cell Infect Microbiol"},{"key":"2208_CR81","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02247-21","author":"S McCallin","year":"2022","unstructured":"McCallin S, Menzi C, Lassen S, Daraspe J, Oechslin F, Moreillon P (2022) Antibiotic exposure leads to reduced phage susceptibility in Vancomycin intermediate Staphylococcus aureus (VISA). Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.02247-21","journal-title":"Antimicrob Agents Chemother"},{"key":"2208_CR83","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/JFB14050244","volume":"14","author":"A Menichetti","year":"2023","unstructured":"Menichetti A, Mavridi-Printezi A, Mordini D, Montalti M (2023) Effect of size, shape and surface functionalization on the antibacterial activity of silver nanoparticles. J Funct Biomater 14:244. https:\/\/doi.org\/10.3390\/JFB14050244","journal-title":"J Funct Biomater"},{"key":"2208_CR84","doi-asserted-by":"publisher","unstructured":"Miller WR, Bayer AS, Arias CA. Mechanism of action and resistance to daptomycin in Staphylococcus aureus and Enterococci n.d. https:\/\/doi.org\/10.1101\/cshperspect.a026997.","DOI":"10.1101\/cshperspect.a026997"},{"key":"2208_CR85","doi-asserted-by":"publisher","first-page":"100232","DOI":"10.1016\/J.SLASD.2025.100232","volume":"33","author":"G Muteeb","year":"2025","unstructured":"Muteeb G, Kazi RNA, Aatif M, Azhar A, Oirdi M El, Farhan M (2025) Antimicrobial resistance: linking molecular mechanisms to public health impact. SLAS Discov 33:100232. https:\/\/doi.org\/10.1016\/J.SLASD.2025.100232","journal-title":"SLAS Discov"},{"key":"2208_CR86","doi-asserted-by":"publisher","DOI":"10.26452\/ijrps.v11i1.1866","author":"AP Nath","year":"2020","unstructured":"Nath AP, Balasubramanian A, Ramalingam K (2020) Cephalosporins: an imperative antibiotic over the generations. Int J Res Pharma Sci. https:\/\/doi.org\/10.26452\/ijrps.v11i1.1866","journal-title":"Int J Res Pharma Sci"},{"key":"2208_CR87","doi-asserted-by":"publisher","unstructured":"Nesbitt WJ, Aronoff D (2023). Amikacin. Kucers the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, Seventh Edition:1009\u201327. https:\/\/doi.org\/10.1201\/9781315152110.","DOI":"10.1201\/9781315152110"},{"key":"2208_CR88","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.3390\/IJMS24065133","volume":"24","author":"M Noga","year":"2023","unstructured":"Noga M, Milan J, Frydrych A, Jurowski K (2023) Toxicological aspects, safety assessment, and green toxicology of silver nanoparticles (AgNPs)\u2014critical review: state of the art. Int J Mol Sci 24:5133. https:\/\/doi.org\/10.3390\/IJMS24065133","journal-title":"Int J Mol Sci"},{"key":"2208_CR89","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/17425247.2025.2459756","volume":"22","author":"VO Nyandoro","year":"2025","unstructured":"Nyandoro VO, Ismail EA, Tageldin A, Gafar MA, Peters XQ, Mautsoe R et al (2025) Potential of nanocarrier-mediated delivery of vancomycin for MRSA infections. Expert Opin Drug Deliv 22:347\u201365. https:\/\/doi.org\/10.1080\/17425247.2025.2459756","journal-title":"Expert Opin Drug Deliv"},{"key":"2208_CR90","doi-asserted-by":"publisher","first-page":"107088","DOI":"10.1016\/J.MICPATH.2024.107088","volume":"197","author":"DB Olawade","year":"2024","unstructured":"Olawade DB, Fapohunda O, Egbon E, Ebiesuwa OA, Usman SO, Faronbi AO et al (2024) Phage therapy: a targeted approach to overcoming antibiotic resistance. Microb Pathog 197:107088. https:\/\/doi.org\/10.1016\/J.MICPATH.2024.107088","journal-title":"Microb Pathog"},{"key":"2208_CR91","doi-asserted-by":"publisher","first-page":"10539","DOI":"10.1038\/S41598-023-37178-X","volume":"13","author":"JO Olugbodi","year":"2023","unstructured":"Olugbodi JO, Lawal B, Bako G, Onikanni AS, Abolenin SM, Mohammud SS et al (2023) Effect of sub-dermal exposure of silver nanoparticles on hepatic, renal, and cardiac functions accompanying oxidative damage in male Wistar rats. Sci Rep 13:10539\u201310539. https:\/\/doi.org\/10.1038\/S41598-023-37178-X","journal-title":"Sci Rep"},{"issue":"2","key":"2208_CR93","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/ANTIBIOTICS14020207","volume":"14","author":"N Parvin","year":"2025","unstructured":"Parvin N, Joo SW, Mandal TK (2025) Nanomaterial-based strategies to combat antibiotic resistance: mechanisms and applications. Antibiotics 14(2):207. https:\/\/doi.org\/10.3390\/ANTIBIOTICS14020207","journal-title":"Antibiotics"},{"key":"2208_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010012","author":"Q Peng","year":"2023","unstructured":"Peng Q, Tang X, Dong W, Sun N, Yuan W (2023) A review of biofilm formation of Staphylococcus aureus and its regulation mechanism. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics12010012","journal-title":"Antibiotics"},{"key":"2208_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00952","author":"RM Pinto","year":"2020","unstructured":"Pinto RM, Soares FA, Reis S, Nunes C, Van Dijck P (2020) Innovative strategies toward the disassembly of the EPS matrix in bacterial biofilms. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.00952","journal-title":"Front Microbiol"},{"key":"2208_CR96","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","volume":"44","author":"DP Pires","year":"2020","unstructured":"Pires DP, Costa AR, Pinto G, Meneses L, Azeredo J (2020) Current challenges and future opportunities of phage therapy. FEMS Microbiol Rev 44:684\u2013700. https:\/\/doi.org\/10.1093\/femsre\/fuaa017","journal-title":"FEMS Microbiol Rev"},{"key":"2208_CR97","doi-asserted-by":"publisher","first-page":"152317","DOI":"10.1016\/J.IMBIO.2022.152317","volume":"228","author":"K Pondman","year":"2023","unstructured":"Pondman K, Le Gac S, Kishore U (2023) Nanoparticle-induced immune response: health risk versus treatment opportunity? Immunobiology 228:152317. https:\/\/doi.org\/10.1016\/J.IMBIO.2022.152317","journal-title":"Immunobiology"},{"key":"2208_CR98","doi-asserted-by":"publisher","first-page":"101743","DOI":"10.1016\/J.JAFR.2025.101743","volume":"19","author":"B Qu","year":"2025","unstructured":"Qu B, Xiao Z, Luo Y (2025) Sustainable nanotechnology for food preservation: synthesis, mechanisms, and applications of zinc oxide nanoparticles. J Agric Food Res 19:101743. https:\/\/doi.org\/10.1016\/J.JAFR.2025.101743","journal-title":"J Agric Food Res"},{"key":"2208_CR99","doi-asserted-by":"publisher","DOI":"10.1080\/08927014.2011.631169","author":"M Rahman","year":"2011","unstructured":"Rahman M, Kim S, Kim SM, Seol SY, Kim J (2011) Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling. https:\/\/doi.org\/10.1080\/08927014.2011.631169","journal-title":"Biofouling"},{"key":"2208_CR100","doi-asserted-by":"publisher","DOI":"10.2139\/SSRN.4100442","author":"KK Rathinam","year":"2022","unstructured":"Rathinam KK, Immanuel JM (2022) Prevalence of methicillin-resistant staphylococcus aureus (MRSA) in India: a systematic review and meta-analysis. SSRN Electron J. https:\/\/doi.org\/10.2139\/SSRN.4100442","journal-title":"SSRN Electron J"},{"key":"2208_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-36694-8","volume":"14","author":"A Rimon","year":"2023","unstructured":"Rimon A, Rakov C, Lerer V, Sheffer-Levi S, Oren SA, Shlomov T et al (2023) Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions. Nat Commun 14:1\u201318. https:\/\/doi.org\/10.1038\/s41467-023-36694-8","journal-title":"Nat Commun"},{"key":"2208_CR102","doi-asserted-by":"publisher","first-page":"117048","DOI":"10.1016\/J.BCP.2025.117048","volume":"239","author":"PC Rosado","year":"2025","unstructured":"Rosado PC, Marques MM, Justino GC (2025) Targeting MRSA penicillin-binding protein 2a: structural insights, allosteric mechanisms, and the potential of adjuvant inhibitors. Biochem Pharmacol 239:117048. https:\/\/doi.org\/10.1016\/J.BCP.2025.117048","journal-title":"Biochem Pharmacol"},{"key":"2208_CR103","doi-asserted-by":"publisher","first-page":"e65836","DOI":"10.7554\/ELIFE.65836","volume":"10","author":"A Sabnis","year":"2021","unstructured":"Sabnis A, Hagart KLH, Kl\u00f6ckner A, Becce M, Evans LE, Furniss RCD et al (2021) Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. Elife 10:e65836. https:\/\/doi.org\/10.7554\/ELIFE.65836","journal-title":"Elife"},{"key":"2208_CR104","doi-asserted-by":"publisher","first-page":"e70414","DOI":"10.7759\/CUREUS.70414","volume":"16","author":"K Sahoo","year":"2024","unstructured":"Sahoo K, Meshram S (2024) The evolution of phage therapy: a comprehensive review of current applications and future innovations. Cureus 16:e70414. https:\/\/doi.org\/10.7759\/CUREUS.70414","journal-title":"Cureus"},{"key":"2208_CR105","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/NANO10020292","volume":"10","author":"E S\u00e1nchez-L\u00f3pez","year":"2020","unstructured":"S\u00e1nchez-L\u00f3pez E, Gomes D, Esteruelas G, Bonilla L, Lopez-Machado AL, Galindo R et al (2020) Metal-based nanoparticles as antimicrobial agents: an overview. Nanomaterials 10:292. https:\/\/doi.org\/10.3390\/NANO10020292","journal-title":"Nanomaterials"},{"issue":"2","key":"2208_CR106","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/CHEMISTRY4020026","volume":"4","author":"PB Santhosh","year":"2022","unstructured":"Santhosh PB, Genova J, Chamati H (2022) Green synthesis of gold nanoparticles: an eco-friendly approach. Chemistry 4(2):345\u2013369. https:\/\/doi.org\/10.3390\/CHEMISTRY4020026","journal-title":"Chemistry"},{"key":"2208_CR107","doi-asserted-by":"publisher","first-page":"128689","DOI":"10.1016\/J.CHEMOSPHERE.2020.128689","volume":"269","author":"MH Sayadi","year":"2021","unstructured":"Sayadi MH, Pavlaki MD, Martins R, Mansouri B, Tyler CR, Kharkan J et al (2021) Bioaccumulation and toxicokinetics of zinc oxide nanoparticles (ZnO NPs) co-exposed with graphene nanosheets (GNs) in the blackfish (Capoeta fusca). Chemosphere 269:128689. https:\/\/doi.org\/10.1016\/J.CHEMOSPHERE.2020.128689","journal-title":"Chemosphere"},{"key":"2208_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-79924-9","volume":"14","author":"AMS Shein","year":"2024","unstructured":"Shein AMS, Wannigama DL, Hurst C, Monk PN, Amarasiri M, Wongsurawat T et al (2024) Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae. Sci Rep 14:1\u201320. https:\/\/doi.org\/10.1038\/s41598-024-79924-9","journal-title":"Sci Rep"},{"key":"2208_CR109","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/J.MEDMIC.2023.100084","volume":"16","author":"P Shree","year":"2023","unstructured":"Shree P, Singh CK, Sodhi KK, Surya JN, Singh DK (2023) Biofilms: understanding the structure and contribution towards bacterial resistance to antibiotics. Med Microecol 16:100084. https:\/\/doi.org\/10.1016\/J.MEDMIC.2023.100084","journal-title":"Med Microecol"},{"key":"2208_CR110","doi-asserted-by":"publisher","unstructured":"Shutter MC, Akhondi H. Tetracycline (2023) Kucers the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, Seventh Edition: 1195\u2013203. https:\/\/doi.org\/10.1201\/9781315152110.","DOI":"10.1201\/9781315152110"},{"key":"2208_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/app10113824","author":"S Siddique","year":"2020","unstructured":"Siddique S, Chow JCL (2020) Gold nanoparticles for drug delivery and cancer therapy. Appl Sci. https:\/\/doi.org\/10.3390\/app10113824","journal-title":"Appl Sci"},{"key":"2208_CR112","doi-asserted-by":"publisher","DOI":"10.1093\/JACAMR\/DLAC046","author":"PJ Simner","year":"2022","unstructured":"Simner PJ, Cherian J, Suh GA, Bergman Y, Beisken S, Fackler J et al (2022) Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitis. JAC-Antimicrob Resistance. https:\/\/doi.org\/10.1093\/JACAMR\/DLAC046","journal-title":"JAC-Antimicrob Resistance"},{"key":"2208_CR113","doi-asserted-by":"publisher","first-page":"368","DOI":"10.15698\/mic2024.11.839","volume":"11","author":"S Sinha","year":"2024","unstructured":"Sinha S, Aggarwal S, Singh DV (2024) Efflux pumps: gatekeepers of antibiotic resistance in Staphylococcus aureus biofilms. Microb Cell 11:368\u201377. https:\/\/doi.org\/10.15698\/mic2024.11.839","journal-title":"Microb Cell"},{"key":"2208_CR114","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.CELL.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT (2023) Phage therapy: from biologic mechanisms to future directions. Cell 186:17. https:\/\/doi.org\/10.1016\/J.CELL.2022.11.017","journal-title":"Cell"},{"key":"2208_CR200","doi-asserted-by":"publisher","unstructured":"Suchy W, Bu\u015b Z, Kr\u00f3l M, Dykas K (2024) Adverse reactions to fluoroquinolones \u2013 Focus on tendinopathy, QT prolongation, and neuropathy: a review. Int J Pharm Phytopharm Res 14(1):23\u201335. https:\/\/doi.org\/10.51847\/hhosb9bttw","DOI":"10.51847\/hhosb9bttw"},{"key":"2208_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19922-x","author":"T Suda","year":"2022","unstructured":"Suda T, Hanawa T, Tanaka M, Tanji Y, Miyanaga K, Hasegawa-Ishii S et al (2022) Modification of the immune response by bacteriophages alters methicillin-resistant Staphylococcus aureus infection. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-19922-x","journal-title":"Sci Rep"},{"key":"2208_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/nano11092156","author":"A Swaidan","year":"2021","unstructured":"Swaidan A, Ghayyem S, Barras A, Addad A, Amin MA, Szunerits S et al (2021) Enhanced antibacterial activity of cus-BSA\/lysozyme under near infrared light irradiation. Nanomaterials. https:\/\/doi.org\/10.3390\/nano11092156","journal-title":"Nanomaterials"},{"key":"2208_CR117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12896-024-00934-6","volume":"25","author":"HR Temsaah","year":"2025","unstructured":"Temsaah HR, Abdelkader K, Ahmed AE, Elgiddawy N, Eldin ZE, Elshebrawy HA et al (2025) Chitosan nano-formulation enhances stability and bactericidal activity of the lytic phage HK6. BMC Biotechnol 25:3. https:\/\/doi.org\/10.1186\/s12896-024-00934-6","journal-title":"BMC Biotechnol"},{"key":"2208_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11033-024-09979-4\/METRICS","volume":"51","author":"S Teymouri","year":"2024","unstructured":"Teymouri S, Pourhajibagher M, Bahador A (2024) A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles. Mol Biol Rep 51:1\u201313. https:\/\/doi.org\/10.1007\/S11033-024-09979-4\/METRICS","journal-title":"Mol Biol Rep"},{"key":"2208_CR119","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40005-021-00525-z","volume":"51","author":"RK Thapa","year":"2021","unstructured":"Thapa RK, Diep DB, T\u00f8nnesen HH (2021) Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and prospects. J Pharm Investig 51:377\u201398. https:\/\/doi.org\/10.1007\/s40005-021-00525-z","journal-title":"J Pharm Investig"},{"key":"2208_CR121","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/BIOLOGY10050388","volume":"10","author":"C Thomas","year":"2021","unstructured":"Thomas C, Gwenin CD (2021) The role of nitroreductases in resistance to nitroimidazoles. Biology (Basel) 10:388. https:\/\/doi.org\/10.3390\/BIOLOGY10050388","journal-title":"Biology (Basel)"},{"key":"2208_CR122","unstructured":"Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine. 2007;2(3):289-300. PMID: 18019829"},{"issue":"4","key":"2208_CR123","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/MICROORGANISMS11040841","volume":"11","author":"E Vittorakis","year":"2023","unstructured":"Vittorakis E, Vic\u0103 ML, Zervaki CO, Vittorakis E, Maraki S, Mavromanolaki VE et al (2023) Examining the prevalence and antibiotic susceptibility of S. aureus strains in hospitals: an analysis of the pvl gene and its co-occurrence with other virulence factors. Microorganisms 11(4):841. https:\/\/doi.org\/10.3390\/MICROORGANISMS11040841","journal-title":"Microorganisms"},{"key":"2208_CR124","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1471-2180-10-217","volume":"10","author":"DE Xavier","year":"2010","unstructured":"Xavier DE, Pico RC, Girardello R, Fehlberg LCC, Gales AC (2010) Efflux pumps expression and its association with porin down-regulation and \u03b2-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol 10:217. https:\/\/doi.org\/10.1186\/1471-2180-10-217","journal-title":"BMC Microbiol"},{"issue":"1","key":"2208_CR125","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/S41429-024-00778-4","volume":"78","author":"W Yang","year":"2025","unstructured":"Yang W, Chen T, Zhou Q, Xu J (2025) Resistance to linezolid in Staphylococcus aureus by mutation, modification, and acquisition of genes. J Antibiot 78(1):4\u201313. https:\/\/doi.org\/10.1038\/S41429-024-00778-4","journal-title":"J Antibiot"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-025-02208-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-025-02208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:17:18Z","timestamp":1764224238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-025-02208-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":121,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2208"],"URL":"https:\/\/doi.org\/10.1007\/s10482-025-02208-3","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"value":"0003-6072","type":"print"},{"value":"1572-9699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}],"article-number":"196"}}